CANbridge Pharmaceuticals Inc. (1228.HK)

HKD 0.16

(0.65%)

Net Income Summary of CANbridge Pharmaceuticals Inc.

CANbridge Pharmaceuticals Inc.'s latest annual net income in 2023 was -378.83 Million CNY , up 21.64% from previous year.
CANbridge Pharmaceuticals Inc.'s latest quarterly net income in 2024 Q2 was -123.63 Million CNY , down 0.0% from previous quarter.
CANbridge Pharmaceuticals Inc. reported an annual net income of -483.47 Million CNY in 2022, up 55.11% from previous year.
CANbridge Pharmaceuticals Inc. reported an annual net income of -1.07 Billion CNY in 2021, down -27.3% from previous year.
CANbridge Pharmaceuticals Inc. reported a quarterly net income of -123.63 Million CNY for 2024 Q1, down -53.89% from previous quarter.
CANbridge Pharmaceuticals Inc. reported a quarterly net income of -80.33 Million HKD for 2023 Q3, up 26.35% from previous quarter.

Annual Net Income Chart of CANbridge Pharmaceuticals Inc. (2023 - 2019)

Historical Annual Net Income of CANbridge Pharmaceuticals Inc. (2023 - 2019)

Year	Net Income	Net Income Growth
2023	-378.83 Million CNY	21.64%
2022	-483.47 Million CNY	55.11%
2021	-1.07 Billion CNY	-27.3%
2020	-846.04 Million CNY	-288.67%
2019	-217.67 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-123.63 Million CNY	0.0%
2024 Q1	-123.63 Million CNY	-53.89%
2023 Q3	-80.33 Million HKD	26.35%
2023 FY	-378.83 Million CNY	21.64%
2023 Q2	-109.08 Million CNY	0.0%
2023 Q1	-109.08 Million CNY	6.95%
2023 Q4	-80.33 Million CNY	0.0%
2022 Q2	-124.5 Million CNY	0.0%
2022 Q1	-124.5 Million CNY	66.02%
2022 FY	-483.47 Million CNY	55.11%
2022 Q4	-117.23 Million CNY	0.0%
2022 Q3	-117.23 Million CNY	5.84%
2021 Q1	-112.36 Million CNY	67.4%
2021 FY	-1.07 Billion CNY	-27.3%
2021 Q4	-366.4 Million CNY	0.0%
2021 Q3	-366.4 Million CNY	-58.04%
2021 Q2	-231.84 Million CNY	-106.33%
2020 Q4	-344.65 Million CNY	0.0%
2020 Q2	-26.2 Million CNY	79.93%
2020 Q3	-344.65 Million CNY	-1215.38%
2020 Q1	-130.52 Million CNY	0.0%
2020 FY	-846.04 Million CNY	-288.67%
2019 FY	-217.67 Million CNY	0.0%

Peer Net Income Comparison of CANbridge Pharmaceuticals Inc.

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	634.507%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	2296.157%